Reprieve for Diabetic Peripheral Neuropathy

About Regenesis

Regenesis operates as a commercial-stage medical device company, not a cell therapy biotech as initially suggested. It has pivoted to commercializing the Reprieve electromagnetic diathermy system, a home-use device for chronic pain, with a significant focus on serving US military veterans. The company has established a direct sales model, reported historical revenue growth, and has clinical evidence for conditions like diabetic peripheral neuropathy and plantar fasciitis. Its core technology, originally conceived for cell proliferation induction, is now applied as a physical stimulus device for pain relief and tissue healing.

Therapeutic Areas